Updated Hypertension Guidelines Show Survival Benefits

A new study quantifies the real-world impact of the 2025 AHA/ACC hypertension guidelines, showing that nearly 1 in 3 adults are newly eligible for treatment but over 40% remain untreated. The projected 200,000+ lives saved over a decade is a powerful public health signal. It reinforces the use of the PREVENT risk calculator and highlights specific medications (HCTZ, lisinopril, diltiazem). Additionally, a new study identifies cortisol as a hidden cause in 27% of resistant hypertension cases, potentially shifting diagnostic approaches. This directly affects clinical decisions and patient outcomes for a chronic condition.